BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cryptosporidiosis readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Cryptosporidiosis\, f
 rom ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07249463-11251@assetmemo.bio
DTSTAMP:20261121T005030Z
DTSTART;VALUE=DATE:20270323
DTEND;VALUE=DATE:20270324
SUMMARY:EDI048: Phase 2 readout est. (NCT07249463)
DESCRIPTION:EDI048\, phase 2\, Cryptosporidiosis.\nStudy: Study Testing the
  Efficacy\, Safety\, and Tolerability of EDI048 in Cryptosporidium Infecti
 on Model in Healthy Adults\nEstimated primary completion: 23 March 2027. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/edi048#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07249463
URL:https://assetmemo.bio/drug/edi048#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
